Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis.

Kaka, Nagham; Hafazalla, Karim; Samawi, Haider; Simpkin, Andrew; Perry, James; Sahgal, Arjun; Das, Sunit

Kaka, Nagham; Hafazalla, Karim; Samawi, Haider; Simpkin, Andrew; Perry, James; Sahgal, Arjun; Das, Sunit.

Afiliação

Kaka N; School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland. N.Kaka1@nuigalway.ie.
Hafazalla K; Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA. karim.hafazalla@jefferson.edu.
Samawi H; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON M5B 1A6, Canada. karim.hafazalla@jefferson.edu.
Simpkin A; Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada. SamawiH@smh.ca.
Perry J; School of Mathematics, Statistics and Applied Mathematics, National University of Ireland, H91 TK33 Galway, Ireland. andrew.simpkin@insight-centre.org.
Sahgal A; Department of Neurology, Sunnybrook Hospital, Toronto, ON M4N 3M5, Canada. james.perry@sunnybrook.ca.
Das S; Department of Radiation Oncology, Sunnybrook Hospital, Toronto, ON M4N 3M5, Canada. Arjun.Sahgal@sunnybrook.ca.

Cancers (Basel) ; 11(11)2019 Nov 04.

Article em En | MEDLINE | ID: mdl-31689995

Palavras-chave

bevacizumab; glioblastoma; meta-analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google